MCRB · Seres Therapeutics, Inc.

Summary

Seres Therapeutics, Inc. announced its financial results for the quarter on March 12, 2026, under Item 2.02. The Company also posted an updated corporate presentation on its website under Item 7.01, with Exhibits 99.1 and 99.2 furnished in connection therewith.

Key takeaways

• Announcement date: March 12, 2026
• Item 2.02: Results of Operations and Financial Condition
• Item 7.01: Regulation FD Disclosure via updated corporate presentation
• Exhibits 99.1 (Item 2.02) and 99.2 (Item 7.01) furnished
• Presentation posted in 'Investors and News' section of www.serestherapeutics.com